Zebrafish models of fetal alcohol spectrum disorders.

Yohaan Fernandes, C Ben Lovely
Author Information
  1. Yohaan Fernandes: Department of Biology, University of South Dakota, Vermillion, South Dakota, USA.
  2. C Ben Lovely: Department of Biochemistry and Molecular Genetics, Alcohol Research Center, University of Louisville, Louisville, Kentucky, USA. ORCID

Abstract

Fetal alcohol spectrum disorder (FASD) describes a wide range of structural deficits and cognitive impairments. FASD impacts up to 5% of children born in the United States each year, making ethanol one of the most common teratogens. Due to limitations and ethical concerns, studies in humans are limited in their ability to study FASD. Animal models have proven critical in identifying and characterizing the mechanisms underlying FASD. In this review, we will focus on the attributes of zebrafish that make it a strong model in which to study ethanol-induced developmental defects. Zebrafish have several attributes that make it an ideal model in which to study FASD. Zebrafish produced large numbers of externally fertilized, translucent embryos. With a high degree of genetic amenability, zebrafish are at the forefront of identifying and characterizing the gene-ethanol interactions that underlie FASD. Work from multiple labs has shown that embryonic ethanol exposures result in defects in craniofacial, cardiac, ocular, and neural development. In addition to structural defects, ethanol-induced cognitive and behavioral impairments have been studied in zebrafish. Building upon these studies, work has identified ethanol-sensitive loci that underlie the developmental defects. However, analyses show there is still much to be learned of these gene-ethanol interactions. The zebrafish is ideally suited to expand our understanding of gene-ethanol interactions and their impact on FASD. Because of the conservation of gene function between zebrafish and humans, these studies will directly translate to studies of candidate genes in human populations and allow for better diagnosis and treatment of FASD.

Keywords

References

  1. Neuropharmacology. 2005 Mar;48(3):426-34 [PMID: 15721175]
  2. Dev Biol. 1998 Nov 15;203(2):382-99 [PMID: 9808788]
  3. Obstet Gynecol Surv. 2017 Feb;72(2):123-135 [PMID: 28218773]
  4. Neurotoxicol Teratol. 2004 Nov-Dec;26(6):769-81 [PMID: 15451041]
  5. Mol Brain. 2014 Sep 16;7:67 [PMID: 25223405]
  6. PLoS One. 2014 Nov 10;9(11):e112851 [PMID: 25383948]
  7. Alcohol Clin Exp Res. 2014 Jul;38(7):1874-82 [PMID: 24962712]
  8. Aquat Toxicol. 2006 Dec 30;80(4):396-404 [PMID: 17125851]
  9. Alcohol Clin Exp Res. 2001 Jan;25(1):60-9 [PMID: 11198716]
  10. Neuropsychol Rev. 2011 Jun;21(2):186-203 [PMID: 21499982]
  11. Neurosci Biobehav Rev. 2007;31(2):192-201 [PMID: 16930704]
  12. Neurotoxicology. 2009 May;30(3):459-70 [PMID: 19442832]
  13. Int J Dev Biol. 1996 Feb;40(1):221-7 [PMID: 8735932]
  14. Neuroscience. 2012 Mar 15;205:154-66 [PMID: 22244974]
  15. Alcohol. 2019 Mar;75:113-121 [PMID: 30640074]
  16. Behav Brain Res. 2011 Jan 1;216(1):66-76 [PMID: 20654657]
  17. Alcohol Clin Exp Res. 2009 Apr;33(4):601-9 [PMID: 19183139]
  18. J Dev Behav Pediatr. 2015 Apr;36(3):197-202 [PMID: 25767932]
  19. BMC Biol. 2021 Jul 1;19(1):134 [PMID: 34210294]
  20. Alcohol Clin Exp Res. 2001 Oct;25(10):1523-35 [PMID: 11696674]
  21. Pharmacol Biochem Behav. 1996 Dec;55(4):501-13 [PMID: 8981580]
  22. Birth Defects Res A Clin Mol Teratol. 2015 Dec;103(12):1046-57 [PMID: 26470995]
  23. Acta Paediatr. 2020 Oct;109(10):1926-1927 [PMID: 32613662]
  24. Neurotoxicol Teratol. 2002 Nov-Dec;24(6):759-66 [PMID: 12460658]
  25. Lancet. 1973 Jun 9;1(7815):1267-71 [PMID: 4126070]
  26. Dev Biol. 1998 Sep 15;201(2):185-201 [PMID: 9740658]
  27. Dev Biol. 2008 Aug 15;320(2):391-401 [PMID: 18602094]
  28. Pediatrics. 2014 Nov;134(5):855-66 [PMID: 25349310]
  29. Biochem Cell Biol. 2018 Apr;96(2):237-240 [PMID: 28834683]
  30. Curr Top Dev Biol. 2015;115:235-69 [PMID: 26589928]
  31. Birth Defects Res B Dev Reprod Toxicol. 2006 Feb;77(1):29-39 [PMID: 16496295]
  32. Natl Vital Stat Rep. 2015 Aug 6;64(9):1-30 [PMID: 26270610]
  33. Neurotoxicol Teratol. 2011 Nov-Dec;33(6):698-707 [PMID: 21658445]
  34. Dev Biol. 2016 Jul 15;415(2):314-325 [PMID: 26777098]
  35. Alcohol Res Health. 2011;34(1):121-31 [PMID: 23580049]
  36. Neuropsychol Rev. 2011 Jun;21(2):73-80 [PMID: 21499711]
  37. Int J Legal Med. 2008 Mar;122(2):129-34 [PMID: 17572905]
  38. Development. 1996 Dec;123:329-44 [PMID: 9007253]
  39. World Neurosurg. 2019 Oct;130:454-458 [PMID: 31252079]
  40. Addiction. 2019 Jul;114(7):1150-1172 [PMID: 30831001]
  41. Exp Biol Med (Maywood). 2005 Jun;230(6):366-75 [PMID: 15956766]
  42. Alcohol Clin Exp Res. 2011 Jul;35(7):1293-304 [PMID: 21410487]
  43. Zebrafish. 2016 Oct;13(5):391-8 [PMID: 27186793]
  44. Int J Dev Neurosci. 2010 Jun;28(4):283-8 [PMID: 20394815]
  45. Orthod Craniofac Res. 2017 Jun;20 Suppl 1:8-11 [PMID: 28643932]
  46. Alcohol Clin Exp Res. 2010 Jun;34(6):1013-21 [PMID: 20374213]
  47. Neurotoxicol Teratol. 2004 Nov-Dec;26(6):757-68 [PMID: 15451040]
  48. Alcohol Clin Exp Res. 2009 Jul;33(7):1238-45 [PMID: 19389189]
  49. Alcohol Clin Exp Res. 1991 Jun;15(3):568-72 [PMID: 1877746]
  50. Alcohol. 2010 Nov-Dec;44(7-8):707-15 [PMID: 20036484]
  51. Alcohol Clin Exp Res. 2019 Aug;43(8):1702-1713 [PMID: 31206717]
  52. N Engl J Med. 2016 Mar 3;374(9):843-52 [PMID: 26962904]
  53. Alcohol Clin Exp Res. 1991 Jun;15(3):565-7 [PMID: 1877745]
  54. Genes Brain Behav. 2009 Aug;8(6):586-99 [PMID: 19243447]
  55. Behav Brain Res. 2014 May 15;265:181-7 [PMID: 24594368]
  56. Pharmacol Biochem Behav. 2003 Jan;74(2):471-80 [PMID: 12479969]
  57. Front Pediatr. 2014 Sep 03;2:93 [PMID: 25232537]
  58. Neurosci Biobehav Rev. 2007;31(2):168-71 [PMID: 17224346]
  59. MMWR Morb Mortal Wkly Rep. 2009 May 22;58(19):529-32 [PMID: 19478721]
  60. Zygote. 1996 May;4(2):101-8 [PMID: 8913023]
  61. Nat Rev Genet. 2007 May;8(5):353-67 [PMID: 17440532]
  62. Alcohol Clin Exp Res. 2008 Oct;32(10):1763-73 [PMID: 18652595]
  63. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Dec 3;55:94-100 [PMID: 24690524]
  64. Alcohol Clin Exp Res. 2011 Sep;35(9):1644-61 [PMID: 21554333]
  65. BMC Neurosci. 2010 Aug 02;11:90 [PMID: 20678210]
  66. Development. 2003 Oct;130(20):4769-84 [PMID: 12952899]
  67. Lancet. 2016 Mar 5;387(10022):978-987 [PMID: 26777270]
  68. Front Genet. 2014 Dec 11;5:436 [PMID: 25566321]
  69. Birth Defects Res. 2020 Mar 1;112(4):367-379 [PMID: 31774246]
  70. Alcohol Clin Exp Res. 2001 Dec;25(12):1719-22 [PMID: 11781503]
  71. Lancet Glob Health. 2017 Mar;5(3):e290-e299 [PMID: 28089487]
  72. MMWR Morb Mortal Wkly Rep. 2007 Jan 19;56(2):25-9 [PMID: 17230142]
  73. Int J Neuropsychopharmacol. 2015 Jan 07;18(6): [PMID: 25568285]
  74. Nat Rev Genet. 2002 Sep;3(9):717-24 [PMID: 12209146]
  75. Genet Epidemiol. 2011 Sep;35(6):469-78 [PMID: 21618603]
  76. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Aug 30;110:110327 [PMID: 33864849]
  77. Semin Cell Dev Biol. 2009 Oct;20(8):986-97 [PMID: 19761865]
  78. Birth Defects Res A Clin Mol Teratol. 2015 Aug;103(8):680-91 [PMID: 26033863]
  79. Birth Defects Res A Clin Mol Teratol. 2009 Jun;85(6):556-67 [PMID: 19235835]
  80. Dis Model Mech. 2021 Jun 1;14(6): [PMID: 34137816]
  81. Am J Med Genet. 1993 Nov 1;47(6):857-61 [PMID: 8279483]
  82. Ther Drug Monit. 2003 Apr;25(2):132-6 [PMID: 12657907]
  83. Genesis. 2019 Jan;57(1):e23278 [PMID: 30614633]
  84. Lancet. 1973 Nov 3;302(7836):999-1001 [PMID: 4127281]
  85. Neurotoxicol Teratol. 2004 Nov-Dec;26(6):737-43 [PMID: 15451038]
  86. Birth Defects Res C Embryo Today. 2014 Sep;102(3):210-20 [PMID: 25219761]
  87. JAMA. 2018 Feb 6;319(5):474-482 [PMID: 29411031]
  88. Biochim Biophys Acta. 2015 Feb;1849(2):73-83 [PMID: 24928143]
  89. Behav Brain Res. 2015 Oct 1;292:102-108 [PMID: 26097005]
  90. Birth Defects Res A Clin Mol Teratol. 2011 Mar;91(3):129-41 [PMID: 21308976]
  91. Dev Disabil Res Rev. 2009;15(3):176-92 [PMID: 19731384]
  92. Wiley Interdiscip Rev Dev Biol. 2017 Jan;6(1): [PMID: 27626243]
  93. Front Cell Dev Biol. 2019 Mar 04;7:13 [PMID: 30886848]
  94. Matern Child Health J. 2009 Mar;13(2):274-85 [PMID: 18317893]
  95. Ann N Y Acad Sci. 2006 Sep;1076:657-9 [PMID: 17119243]
  96. Dev Cell. 2002 Jan;2(1):103-13 [PMID: 11782318]
  97. Birth Defects Res A Clin Mol Teratol. 2008 Apr;82(4):224-31 [PMID: 18338389]
  98. Alcohol Alcohol. 2020 Oct 20;55(6):581-590 [PMID: 32886092]
  99. Alcohol Clin Exp Res. 2010 Jan;34(1):98-111 [PMID: 19860813]
  100. Eur J Hum Genet. 2012 Oct;20(10):1058-62 [PMID: 22473090]
  101. Aerosp Med Hum Perform. 2019 May 1;90(5):488-491 [PMID: 31023411]
  102. Sci Rep. 2018 Jan 10;8(1):347 [PMID: 29321611]
  103. Sci Total Environ. 2019 Oct 10;686:311-321 [PMID: 31181518]
  104. Pediatrics. 2006 Jan;117(1):168-83 [PMID: 16396875]
  105. Alcohol Clin Exp Res. 2014 Aug;38(8):2160-3 [PMID: 25156611]
  106. Alcohol Clin Exp Res. 2000 Jan;24(1):102-9 [PMID: 10656199]
  107. Dev Disabil Res Rev. 2009;15(3):200-8 [PMID: 19731387]
  108. Biochem Cell Biol. 2018 Apr;96(2):88-97 [PMID: 28817785]
  109. Dev Cell. 2011 Jul 19;21(1):48-64 [PMID: 21763608]
  110. Alcohol. 2019 Jun;77:147-154 [PMID: 30660600]
  111. Exp Biol Med (Maywood). 2005 Jun;230(6):357-65 [PMID: 15956765]
  112. Alcohol. 2014 Sep;48(6):595-602 [PMID: 25012627]
  113. Development. 2006 Mar;133(6):1069-77 [PMID: 16481351]
  114. Nat Genet. 2008 Mar;40(3):290-8 [PMID: 18264099]
  115. J Matern Fetal Neonatal Med. 2012 Apr;25 Suppl 1:25-9 [PMID: 22356564]
  116. Alcohol Clin Exp Res. 2016 Jun;40(6):1154-65 [PMID: 27122355]
  117. Dev Cell. 2015 Jan 12;32(1):97-108 [PMID: 25533206]
  118. Teratology. 1997 Nov;56(5):317-26 [PMID: 9451756]
  119. Neurotoxicology. 2017 Sep;62:100-110 [PMID: 28587808]
  120. PLoS One. 2018 Aug 1;13(8):e0201659 [PMID: 30067812]
  121. Alcohol Clin Exp Res. 2014 Mar;38(3):694-703 [PMID: 24164477]
  122. PLoS One. 2016 Aug 24;11(8):e0161205 [PMID: 27556898]
  123. JAMA Pediatr. 2017 Oct 1;171(10):948-956 [PMID: 28828483]
  124. Alcohol Clin Exp Res. 2014 May;38(5):1255-65 [PMID: 24512079]
  125. Zebrafish. 2013 Mar;10(1):52-61 [PMID: 23461415]
  126. Arch Pediatr Adolesc Med. 1997 Nov;151(11):1096-103 [PMID: 9369870]
  127. Dev Dyn. 2013 Oct;242(10):1184-201 [PMID: 23832875]
  128. J Med Genet. 2018 Oct;55(10):641-649 [PMID: 30065072]
  129. Science. 2021 Sep 03;373(6559):1146-1151 [PMID: 34413171]
  130. Am J Med Genet C Semin Med Genet. 2010 Feb 15;154C(1):73-85 [PMID: 20104598]
  131. Genes Dev. 2004 Apr 15;18(8):937-51 [PMID: 15107405]
  132. Birth Defects Res. 2017 Jan 30;109(2):180-185 [PMID: 28398650]
  133. Differentiation. 2007 Jun;75(5):393-403 [PMID: 17286601]
  134. Neurotoxicol Teratol. 2014 Jan-Feb;41:43-50 [PMID: 24263126]
  135. Front Cell Dev Biol. 2020 Nov 16;8:600926 [PMID: 33304906]
  136. PLoS One. 2013 Dec 06;8(12):e83039 [PMID: 24324841]
  137. Alcohol. 2011 Feb;45(1):11-8 [PMID: 20880661]
  138. Am J Med Genet C Semin Med Genet. 2010 Feb 15;154C(1):52-61 [PMID: 20104595]
  139. PLoS One. 2013 Jul 31;8(7):e69574 [PMID: 23936049]
  140. Am Fam Physician. 2017 Oct 15;96(8):515-522 [PMID: 29094891]
  141. Addict Biol. 2021 Jan;26(1):e12867 [PMID: 31919968]
  142. Birth Defects Res. 2019 Jul 15;111(12):700-713 [PMID: 30793540]
  143. Birth Defects Res C Embryo Today. 2011 Mar;93(1):3-11 [PMID: 21425437]
  144. Alcohol Clin Exp Res. 2021 Feb;45(2):457-469 [PMID: 33349933]
  145. Birth Defects Res A Clin Mol Teratol. 2007 Jul;79(7):513-23 [PMID: 17393481]
  146. Birth Defects Res A Clin Mol Teratol. 2013 Jan;97(1):8-27 [PMID: 23184466]
  147. Trends Cell Biol. 2015 Sep;25(9):545-55 [PMID: 26159692]
  148. Alcohol Clin Exp Res. 2000 Mar;24(3):307-14 [PMID: 10776667]
  149. Neurotoxicol Teratol. 2006 May-Jun;28(3):342-8 [PMID: 16574376]
  150. Birth Defects Res A Clin Mol Teratol. 2005 Feb;73(2):114-22 [PMID: 15602753]
  151. Dis Model Mech. 2009 May-Jun;2(5-6):295-305 [PMID: 19380308]
  152. Pharmacol Biochem Behav. 2015 Dec;139 Pt B:103-11 [PMID: 25792292]
  153. Development. 2005 Sep;132(17):3977-88 [PMID: 16049113]
  154. Development. 2003 Mar;130(5):929-40 [PMID: 12538519]
  155. Alcohol Res Health. 2000;24(2):93-104 [PMID: 11199283]
  156. Development. 1996 Dec;123:345-56 [PMID: 9007254]
  157. Alcohol. 2000 Jan;20(1):75-81 [PMID: 10680720]
  158. Biochem Cell Biol. 2018 Apr;96(2):77-87 [PMID: 29069552]
  159. Nature. 2000 May 4;405(6782):76-81 [PMID: 10811221]
  160. Dev Biol. 2005 Mar 1;279(1):193-204 [PMID: 15708568]
  161. Development. 2013 Aug;140(15):3254-65 [PMID: 23861062]
  162. Development. 1997 Jul;124(14):2691-700 [PMID: 9226440]
  163. Community Ment Health J. 2017 Aug;53(6):711-718 [PMID: 28168434]
  164. Development. 2003 May;130(10):2129-38 [PMID: 12668627]
  165. Lab Invest. 2007 Mar;87(3):231-40 [PMID: 17237799]
  166. Bioelectricity. 2019 Dec 1;1(4):260-272 [PMID: 32685918]
  167. Alcohol Clin Exp Res. 2008 May;32(5):874-87 [PMID: 18371156]
  168. Birth Defects Res A Clin Mol Teratol. 2005 Apr;73(4):195-203 [PMID: 15786496]
  169. Nature. 1996 Oct 3;383(6599):407-13 [PMID: 8837770]
  170. Eur J Neurosci. 2018 Jun;47(12):1457-1473 [PMID: 29846983]
  171. J Comp Neurol. 2007 Jun 1;502(4):497-506 [PMID: 17394139]
  172. Lancet Neurol. 2019 Aug;18(8):760-770 [PMID: 31160204]
  173. J Genet Genomics. 2012 Sep 20;39(9):421-33 [PMID: 23021542]
  174. PLoS One. 2012;7(8):e43067 [PMID: 22937012]
  175. Nature. 2013 Apr 25;496(7446):498-503 [PMID: 23594743]
  176. Neurotoxicol Teratol. 2015 Mar-Apr;48:18-27 [PMID: 25599605]
  177. Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10476-81 [PMID: 12140368]
  178. Neurotoxicol Teratol. 2004 Nov-Dec;26(6):745-55 [PMID: 15451039]
  179. J Clin Invest. 2012 Jul;122(7):2337-43 [PMID: 22751109]
  180. PLoS One. 2011;6(5):e20037 [PMID: 21625530]
  181. Neurotoxicol Teratol. 2014 Jul-Aug;44:70-80 [PMID: 24929233]
  182. JAMA. 1991 Apr 17;265(15):1961-7 [PMID: 2008025]
  183. Alcohol Res. 2012;34(3):325-35 [PMID: 23134048]
  184. Alcohol Clin Exp Res. 2020 Jan;44(1):56-65 [PMID: 31742718]
  185. Dev Biol. 2016 Jul 15;415(2):171-187 [PMID: 26808208]
  186. Neurotoxicol Teratol. 2015 Mar-Apr;48:1-8 [PMID: 25599606]
  187. Neurotoxicol Teratol. 2017 May;61:66-73 [PMID: 28223149]
  188. Proc Natl Acad Sci U S A. 2013 Apr 2;110(14):5683-8 [PMID: 23431142]
  189. Development. 2003 Nov;130(22):5375-84 [PMID: 13129848]

Grants

  1. R00 AA023560/NIAAA NIH HHS
  2. R00 AA027567/NIAAA NIH HHS

MeSH Term

Animals
Disease Models, Animal
Fetal Alcohol Spectrum Disorders
Zebrafish

Word Cloud

Created with Highcharts 10.0.0FASDzebrafishdefectsstudiesgene-ethanolinteractionsalcoholspectrumstudyZebrafishstructuralcognitiveimpairmentsethanolhumansmodelsidentifyingcharacterizingwillattributesmakemodelethanol-induceddevelopmentalunderliefetaldisordersFetaldisorderdescribeswiderangedeficitsimpacts5%childrenbornUnitedStatesyearmakingonecommonteratogensDuelimitationsethicalconcernslimitedabilityAnimalprovencriticalmechanismsunderlyingreviewfocusstrongseveralidealproducedlargenumbersexternallyfertilizedtranslucentembryoshighdegreegeneticamenabilityforefrontWorkmultiplelabsshownembryonicexposuresresultcraniofacialcardiacocularneuraldevelopmentadditionbehavioralstudiedBuildinguponworkidentifiedethanol-sensitivelociHoweveranalysesshowstillmuchlearnedideallysuitedexpandunderstandingimpactconservationgenefunctiondirectlytranslatecandidategeneshumanpopulationsallowbetterdiagnosistreatmentbirthenvironmentgenetics

Similar Articles

Cited By